A medical food is specifically formulated for patients, who require medical food as a major part of their dietary supplement during treatment. They are custom-made liquid solutions created with the sole purpose of curing persons suffering from various illnesses. Professionals provide the designed meal to people suffering from various illnesses. It is a specially prepared diet that provides patients with adequate nutrients.

Medical foods are available in different forms such as powders, liquids, and even gum. Moreover, medical foods are more commonly used to treat chronic conditions and diseases through long-term use in an outpatient setting. Manufacturers are developing products for new illness indications, fueling growth of the medical food market. Medical food is specifically tailored to meet the nutritional and metabolic demands of those suffering from a specific illness.

Market Dynamics

Medical foods are also used in the treatment of other gastrointestinal diseases such as diarrhea, constipation, gastroenteritis, peptic ulcer diseases, and colorectal cancer, which is expected to propel market growth over the forecast period. Moreover, the increasing geriatric population suffering from several chronic and neurogenic disorders such as dementia, stroke, multiple sclerosis, and difficulty in swallowing requires specific dietary management, which, in turn, is expected to drive the market growth over the forecast period. For instance in July 2019, Georgetown University entered into a collaboration with National Center for Complementary and Integrative Health (NCCIH), University of Maryland, a United States government agency which explores complementary and alternative medicine, initiated early phase 1 clinical trial to demonstrate the mechanisms of preventing antibiotic-associated diarrhea and the role of probiotics.

Key features of the study

• This report provides in-depth analysis of the U.S. Medical Foods market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. Medical Foods market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. Medical Foods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. Medical Foods market

Market Segmentation

• Food Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Probiotics
    • Probiotic Foods
    • Probiotic Supplements
  • Food Supplements
• Disease Indication Insights (Revenue, USD Bn, 2026 - 2033)
  • Inflammatory Bowel Disease
    • Ulcerative Colitis
    • Cohn’s Disease
  • Irritable Bowel Syndrome
  • Others
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospitals
  • Retail Channel
  • Online Channel
• Key Players Insights
  • Enterome SA
  • Yakult Honsha Co., Ltd.
  • Abbott
  • ExeGi Pharma, LLC.
  • VSL Pharmaceuticals, Inc.
  • Entera Health, Inc.
  • Meiji Holdings Co., Ltd.
  • Danone
  • Nestle S.A.